Terms: = Prostate cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Staging
110 results:
1. Implementation of PSMA PET/CT and alignment of ordering to SNMMI appropriate use criteria in a large network system.
Bennett R; Li EV; Ho AY; Aguiar JA; Neill C; Rowe SP; Patel HD; Savas H; Ross AE
Prostate; 2024 Jun; 84(8):717-722. PubMed ID: 38450787
[TBL] [Abstract] [Full Text] [Related]
2. Fewer systematic prostate core biopsies in clinical stage T1c prostate cancer leads to biochemical recurrence after brachytherapy as monotherapy.
Ozawa Y; Nohara S; Nakamura K; Hattori S; Yagi Y; Nishiyama T; Yorozu A; Monma T; Saito S
Prostate; 2024 Apr; 84(5):502-510. PubMed ID: 38173289
[TBL] [Abstract] [Full Text] [Related]
3. Investigation of radiomics models for predicting biochemical recurrence of advanced prostate cancer on pretreatment MR ADC maps based on automatic image segmentation.
Wang H; Wang K; Ma S; Gao G; Wang X
J Appl Clin Med Phys; 2024 Apr; 25(4):e14244. PubMed ID: 38146796
[TBL] [Abstract] [Full Text] [Related]
4. The prognostic role of next-generation imaging-driven upstaging in newly diagnosed prostate cancer patients.
Bauckneht M; Checcucci E; Cisero E; Rizzo A; Racca M; De Cillis S; Amparore D; De Luca S; Fiori C; Rescigno P; Porpiglia F
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):864-870. PubMed ID: 37935995
[TBL] [Abstract] [Full Text] [Related]
5. Biopsy-free AI-aided precision MRI assessment in prediction of prostate cancer biochemical recurrence.
Hou Y; Jiang KW; Wang LL; Zhi R; Bao ML; Li Q; Zhang J; Qu JR; Zhu FP; Zhang YD
Br J Cancer; 2023 Nov; 129(10):1625-1633. PubMed ID: 37758837
[TBL] [Abstract] [Full Text] [Related]
6. Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical prostatectomy.
Falagario UG; Abbadi A; Remmers S; Björnebo L; Bogdanovic D; Martini A; Valdman A; Carrieri G; Menon M; Akre O; Eklund M; Nordström T; Grönberg H; Lantz A; Wiklund P
JAMA Netw Open; 2023 Sep; 6(9):e2332900. PubMed ID: 37695584
[TBL] [Abstract] [Full Text] [Related]
7. Modified PROMISE criteria for standardized interpretation of gastrin-releasing peptide receptor (GRPR)-targeted PET.
Duan H; Davidzon GA; Moradi F; Liang T; Song H; Iagaru A
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4087-4095. PubMed ID: 37555901
[TBL] [Abstract] [Full Text] [Related]
8. Head-to-Head Comparison of [
García-Zoghby L; Lucas-Lucas C; Amo-Salas M; Soriano-Castrejón ÁM; García-Vicente AM
Curr Oncol; 2023 Jun; 30(7):6271-6288. PubMed ID: 37504324
[TBL] [Abstract] [Full Text] [Related]
9. Presurgical
Djaïleb L; Armstrong WR; Thompson D; Gafita A; Farolfi A; Rajagopal A; Grogan TR; Nguyen K; Benz MR; Hotta M; Barbato F; Ceci F; Schwarzenböck SM; Unterrainer M; Zacho HD; Juarez R; Cooperberg M; Carroll P; Washington S; Reiter RE; Eiber M; Herrmann K; Fendler WP; Czernin J; Hope TA; Calais J
Eur Urol; 2023 Dec; 84(6):588-596. PubMed ID: 37482512
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of MRI-Based staging and Pathologic staging for Predicting Biochemical Recurrence of prostate cancer After Radical prostatectomy.
Merriman KM; Harmon SA; Belue MJ; Yilmaz EC; Blake Z; Lay NS; Phelps TE; Merino MJ; Parnes HL; Law YM; Gurram S; Wood BJ; Choyke PL; Pinto PA; Turkbey B
AJR Am J Roentgenol; 2023 Dec; 221(6):773-787. PubMed ID: 37404084
[No Abstract] [Full Text] [Related]
11. Impact of positive surgical margins (PSMs) after robotic prostatectomy on biochemical recurrence (bcr): Multicenter analysis.
Fiorello N; Di Benedetto A; Brizzi L; Mogorovich A; Summonti D; Silvestri G; Benvenuti S; Sepich CA
Urologia; 2023 Nov; 90(4):647-652. PubMed ID: 37354007
[TBL] [Abstract] [Full Text] [Related]
12. Methylation status of various gene loci in localized prostate cancer: Novel biomarkers for diagnostics and biochemical recurrence.
Eismann L; von Walter P; Jung A; Chaloupka M; Rodler S; Westhofen T; Buchner A; Stief CG; Stadler T; Schlenker B
Urol Oncol; 2023 Jul; 41(7):325.e1-325.e8. PubMed ID: 37179150
[TBL] [Abstract] [Full Text] [Related]
13. Role of radiomic analysis of [
Marturano F; Guglielmo P; Bettinelli A; Zattoni F; Novara G; Zorz A; Sepulcri M; Gregianin M; Paiusco M; Evangelista L
Eur Radiol; 2023 Oct; 33(10):7199-7208. PubMed ID: 37079030
[TBL] [Abstract] [Full Text] [Related]
14. An Australian experience using Tc-PSMA SPECT/CT in the primary diagnosis of prostate cancer and for staging at biochemical recurrence after local therapy.
Duncan I; Ingold N; Martinez-Marroquin E; Paterson C
Prostate; 2023 Jul; 83(10):970-979. PubMed ID: 37051636
[TBL] [Abstract] [Full Text] [Related]
15. Histopathologically Validated Diagnostic Accuracy of PSMA-PET/CT in the Primary and Secondary staging of prostate cancer and the Impact of PSMA-PET/CT on Clinical Management: A Systematic Review and Meta-analysis.
Jeet V; Parkinson B; Song R; Sharma R; Hoyle M
Semin Nucl Med; 2023 Sep; 53(5):706-718. PubMed ID: 37005145
[TBL] [Abstract] [Full Text] [Related]
16. Impact of piflufolastat F-18 PSMA PET imaging on clinical decision-making in prostate cancer across disease states: A retrospective review.
Arafa AT; Jain A; Skrobanek P; Humphrey B; Froelich JW; Antonarakis ES
Prostate; 2023 Jun; 83(9):863-870. PubMed ID: 36999911
[TBL] [Abstract] [Full Text] [Related]
17.
Sonni I; Dal Pra A; O'Connell DP; Ells Z; Benz M; Nguyen K; Yoon SM; Deng J; Smith C; Grogan T; Nickols NG; Cao M; Kishan AU; Calais J
J Nucl Med; 2023 Jun; 64(6):902-909. PubMed ID: 36759200
[TBL] [Abstract] [Full Text] [Related]
18. Narrative review of PET/CT performances at biochemical recurrence in prostate cancer after radical prostatectomy and impact on patient disease management: Revue narrative à propos des performances de la TEP/TDM en cas de récidive biochimique après prostatectomie radicale dans le cancer de la prostate et impact sur la prise en charge des patients.
Lasserre M; Sargos P; Barret E; Beauval JB; Brureau L; Créhange G; Dariane C; Fiard G; Fromont G; Mathieu R; Renard-Penna R; Roubaud G; Ruffion A; Rouprêt M; Ploussard G; Gauthé M;
Prog Urol; 2022 Jun; 32(6S1):6S33-6S42. PubMed ID: 36719645
[TBL] [Abstract] [Full Text] [Related]
19. The Changing Face of cN0M0 prostate cancer Being Found With pN+ After Surgery in the Contemporary Era: Results of an International European Survey on Disease Management.
Sacco M; Gandaglia G; Aas K; Ceci F; Chiu P; Fankhauser CD; Fournier G; Heiddeger I; Kasivisvanathan V; Kesch C; Maggi M; Martini A; Olivier J; Ploussard G; Preisser F; Puche-Sanz I; Rajwa P; Soeterik T; Thibault C; Valerio M; van den Bergh RCN; Zattoni F; Rivas JG; Moschini M; Gillessen S; Bossi A; Gontero P; Marra G;
Clin Genitourin Cancer; 2023 Jun; 21(3):416.e1-416.e10. PubMed ID: 36609130
[TBL] [Abstract] [Full Text] [Related]
20. Comparative Outcomes of Robotic Radical prostatectomy in Patients with Locally Advanced prostate cancer.
Li PI; Chen SJ; Chen YH; Chen WC; Huang CP
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557022
[TBL] [Abstract] [Full Text] [Related]
[Next]
